Skip to main content

Table 2 Salivary flow (mean ± SD) before and after the intervention at different times

From: Comparison of the 1 and 2% pilocarpine mouthwash in a xerostomic population: a randomized clinical trial

Assessment time

Time (mins)

Salivary Flow (ml/min)

P value

2% pilocarpine mouthwash

1% pilocarpine mouthwash

Placebo mouthwash

1st day

0

0.33 ± 0.10

0.33 ± 0.10

0.33 ± 0.10

1.00

45

0.57 ± 0.26a

0.58 ± 0.22a

0.33 ± 0.09

< 0.01*

60

0.76 ± 0.28a,b

0.57 ± 0.19a,b

0.35 ± 0.08

< 0.01*

75

0.72‌ ± 0.26a,b

0.51 ± 0.15a,b

0.33 ± 0.09

< 0.01*

14th day

0

0.35 ± 0.10

0.34 ± 0.08

0.34 ± 0.09

0.93

45

0.64 ± 0.25a

0.56 ± 0.30

0.37 ± 0.14

< 0.01*

60

0.81 ± 0.21a,b

0.54 ± 0.26a,b

0.35 ± 0.12

< 0.01*

75

0.73 ± 0.21a,b

0.50 ± 0.23b

0.38 ± 0.18

< 0.01*

  1. *Statistically significant; asignificant difference with placebo; b significant difference between pilocarpine mouthwashes;